176 related articles for article (PubMed ID: 21426201)
1. K(+) channels as therapeutic targets in oncology.
Stühmer W; Pardo LA
Future Med Chem; 2010 May; 2(5):745-55. PubMed ID: 21426201
[TBL] [Abstract][Full Text] [Related]
2. Targeting K+ channels for cancer therapy.
Conti M
J Exp Ther Oncol; 2004 Jul; 4(2):161-6. PubMed ID: 15500011
[TBL] [Abstract][Full Text] [Related]
3. Targeting ion channels for cancer therapy by repurposing the approved drugs.
Kale VP; Amin SG; Pandey MK
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2747-55. PubMed ID: 25843679
[TBL] [Abstract][Full Text] [Related]
4. Research into the therapeutic roles of two-pore-domain potassium channels.
Es-Salah-Lamoureux Z; Steele DF; Fedida D
Trends Pharmacol Sci; 2010 Dec; 31(12):587-95. PubMed ID: 20951446
[TBL] [Abstract][Full Text] [Related]
5. [Physiology, pharmacology and modelling of potassium channels: focus on SK channels].
Dilly S; Poncin S; Lamy C; Liégeois JF; Seutin V
Med Sci (Paris); 2012 Apr; 28(4):395-402. PubMed ID: 22549867
[TBL] [Abstract][Full Text] [Related]
6. Potassium channels as therapeutic targets for autoimmune disorders.
Wulff H; Beeton C; Chandy KG
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):640-7. PubMed ID: 14579513
[TBL] [Abstract][Full Text] [Related]
7. Potassium channels as targets for therapeutic intervention.
Garcia ML; Kaczorowski GJ
Sci STKE; 2005 Sep; 2005(302):pe46. PubMed ID: 16174819
[TBL] [Abstract][Full Text] [Related]
8. Potassium channels: novel emerging biomarkers and targets for therapy in cancer.
D'Amico M; Gasparoli L; Arcangeli A
Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):53-65. PubMed ID: 22574647
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of cardiac potassium channels.
Li GR; Dong MQ
Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
[TBL] [Abstract][Full Text] [Related]
10. Voltage-Gated Potassium Channels Kv1.3--Potentially New Molecular Target in Cancer Diagnostics and Therapy.
Teisseyre A; Gąsiorowska J; Michalak K
Adv Clin Exp Med; 2015; 24(3):517-24. PubMed ID: 26467143
[TBL] [Abstract][Full Text] [Related]
11. Antifibrillatory agents and potassium channels in the atria: pore block versus channel trafficking.
McEwen DP; Martens JR
Mol Interv; 2009 Apr; 9(2):79-86. PubMed ID: 19401540
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of cardiac potassium channels.
Tamargo J; Caballero R; Gómez R; Valenzuela C; Delpón E
Cardiovasc Res; 2004 Apr; 62(1):9-33. PubMed ID: 15023549
[TBL] [Abstract][Full Text] [Related]
13. Targeting K
Todesca LM; Maskri S; Brömmel K; Thale I; Wünsch B; Koch O; Schwab A
Cell Physiol Biochem; 2021 May; 55(S3):131-144. PubMed ID: 34043300
[TBL] [Abstract][Full Text] [Related]
14. Potassium channels: structures, diseases, and modulators.
Tian C; Zhu R; Zhu L; Qiu T; Cao Z; Kang T
Chem Biol Drug Des; 2014 Jan; 83(1):1-26. PubMed ID: 24119115
[TBL] [Abstract][Full Text] [Related]
15. Novel perspectives in cancer therapy: Targeting ion channels.
Arcangeli A; Becchetti A
Drug Resist Updat; 2015; 21-22():11-9. PubMed ID: 26183291
[TBL] [Abstract][Full Text] [Related]
16. The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease.
Malerba M; Radaeli A; Mancuso S; Polosa R
J Biol Regul Homeost Agents; 2010; 24(2):123-30. PubMed ID: 20487625
[TBL] [Abstract][Full Text] [Related]
17. Discovering potassium channel blockers from synthetic compound database by using structure-based virtual screening in conjunction with electrophysiological assay.
Liu H; Gao ZB; Yao Z; Zheng S; Li Y; Zhu W; Tan X; Luo X; Shen J; Chen K; Hu GY; Jiang H
J Med Chem; 2007 Jan; 50(1):83-93. PubMed ID: 17201412
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of mitochondrial potassium channels: dark side of the field.
Szewczyk A; Kajma A; Malinska D; Wrzosek A; Bednarczyk P; Zabłocka B; Dołowy K
FEBS Lett; 2010 May; 584(10):2063-9. PubMed ID: 20178786
[TBL] [Abstract][Full Text] [Related]
19. TASK Channels Pharmacology: New Challenges in Drug Design.
Bedoya M; Rinné S; Kiper AK; Decher N; González W; Ramírez D
J Med Chem; 2019 Nov; 62(22):10044-10058. PubMed ID: 31260312
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.
Köhler R; Wulff H; Eichler I; Kneifel M; Neumann D; Knorr A; Grgic I; Kämpfe D; Si H; Wibawa J; Real R; Borner K; Brakemeier S; Orzechowski HD; Reusch HP; Paul M; Chandy KG; Hoyer J
Circulation; 2003 Sep; 108(9):1119-25. PubMed ID: 12939222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
